This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.

Share
Stay up to date

Home
Topics
Webinars/Videos
Infographics
Articles
Case Studies
Faculty
Unblocked
Webinar
Stay up to date

Articles

Statin intolerance: time to stop letting it get in the way of treating patients

Banach Maciej

Journal:

The Lancet

First published: August 29, 2022 DOI: 10.1016/S0140-6736(22)01643-9

Abstract

You might also like...

Running time: 1.5 minutes
Webinars/Videos
Q&A with Key Opinion Leaders: AHA Highlights in ASCVD and Lipids
Listen to our key opinion leaders, Prof. Lale Tokgözoğlu and Prof. Chern-En Chiang answer audience questions on ASCVD and Lipidology.
Banach Maciej
Journal:
The Lancet

First published: August 29, 2022 DOI: 10.1016/S0140-6736(22)01643-9
View
- Share
Infographics
Statin-Associated Muscle Symptoms: Challenges and recommendations for diagnosis and management
Statin therapy is a cornerstone for the prevention and treatment of CVD. However, statin associated muscle symptoms (SAMS) are serious side-effects of statin use and often lead to discontinuation of statin therapy. Check out and download our latest infographic highlighting the challenges, and recommendations for diagnosis and management of SAMS.
Banach Maciej
Journal:
The Lancet

First published: August 29, 2022 DOI: 10.1016/S0140-6736(22)01643-9
View
- Share
Case Studies
Quiz of the month – September 2022
How many patients with ASCVD do you treat per week?
Banach Maciej
Journal:
The Lancet

First published: August 29, 2022 DOI: 10.1016/S0140-6736(22)01643-9
Take
- Share
How many patients with ASCVD do you treat per week?
a) 1-5
b) 6-10
c) 10-15
d) 15 or more

Time's up

How would you rate this content?

© John Wiley & Sons, Ltd. All rights reserved.
Privacy Policy
Terms of use
Stay up to date
Cookie Preferences
This Knowledge Hub is supported by Novartis.